Abstract 4325: FXYD5 plays diverse roles in immune evasion and tumor progression in prostate cancerRu Wen, James D. Brooks, Aram Lyu et al.|Cancer Research|2025Cited by 1
CRISPR screen reveal that FXYD5 is a potential ligand for Siglec-7 9337Ru Wen, James D. Brooks, Sharon J. Pitteri et al.|The Journal of Immunology|2025Cited by 0